Welcome to my blog on surgery and related sciences. Here I will express views on the art and science of surgery in general. Any comments and thoughts are most welcomed.

Friday, 9 October 2015

The Lancet, issue 10,0000: Surgery themed issue


How appropriate that the journal named after a surgical instrument would dedicate their 10,000th issue to surgery as such. Indeed, since its fist release it is but true to state that surgery is far from the dominant subject in this worldwide circulated journal.
Well, this has been more than rectified in the current issue, with several small pieces on surgery and historical vignettes, but more important; three randomised controlled trials on surgical themes are included in the issue (more on each of these later), and 3 review papers are included (more on these as well!), covering a wide range of important themes in general surgery, with the main theme being emergency surgery.

To read more on the STICH, PONCHO and Ladies trial go to:
http://www.thelancet.com/journals/lancet/issue/vol386no10000/PIIS0140-6736(15)X0006-7

I'll add in discussions on appendicitis, pancreatitis, diverticulitis, and perforated ulcer later on.

Wednesday, 21 January 2015

2015 and launch of first editorial

Long time since last post here on the blog - my apologies for the vacancy!

As the first post this year I would like to put forward a link to a recently published editorial I wrote for the Scandinavian Journal of Trauma, Resuscitation and Emergency Medicine, that reviewed the progress of the Journal over the past few years. This journal has now really grown and is becoming a major stakeholder in Scandinavian acute medicine, providing a vehicle for academic work from the Nordic countries but also globally.
Please go read the full text editorial here.
Development, year on year

Tuesday, 19 August 2014

Career choice in medicine

Finding your career track has become more easy with this algorithm:

Sunday, 6 April 2014

What is the role of EMAST in cancer?

Prevalence and implications of elevated microsatellite alterations at selected tetranucleotides in cancer

From Watson et al. British Journal of Cancer advance online publication 1 April 2014; doi: 10.1038/bjc.2014.167

Elevated microsatellite alterations at selected tetranucleotides (EMAST), a variation of microsatellite instability (MSI), has been reported in a variety of malignancies (e.g., neoplasias of the lung, head and neck, colorectal region, skin, urinary tract and reproductive organs). EMAST is more prominent at organ sites with potential external exposure to carcinogens (e.g., head, neck, lung, urinary bladder and colon), although the specific molecular mechanisms leading to EMAST remain elusive. Because it is often associated with advanced stages of malignancy, EMAST may be a consequence of rapid cell proliferation and increased mutagenesis. Moreover, defects in DNA mismatch repair enzyme complexes, TP53 mutation status and peritumoural inflammation involving T cells have been described in EMAST tumours. At various tumour sites, EMAST and high-frequency MSI share no clinicopathological features or molecular mechanisms, suggesting their existence as separate entities. Thus EMAST should be explored, because its presence in human cells may reflect both increased risk and the potential for early detection. In particular, the potential use of EMAST in prognosis and prediction may yield novel types of therapeutic intervention, particularly those involving the immune system. 

In a just released review in the BJC we will summarise the current information concerning EMAST in cancer to highlight the knowledge gaps that require further research

Sunday, 30 March 2014

Cellular metabolism in colorectal carcinogenesis: Influence of lifestyle, gut microbiome and metabolic pathways



The interconnectivity between diet, gut microbiota and cell molecular responses is well known; however, only recently has technology allowed the identification of strains of microorganisms harbored in the gastrointestinal tract that may increase susceptibility to cancer. The colonic environment appears to play a role in the development of colon cancer, which is influenced by the human metabolic lifestyle and changes in the gut microbiome. Studying metabolic changes at the cellular level in cancer be useful for developing novel improved preventative measures, such as screening through metabolic breath-tests or treatment options that directly affect the metabolic pathways responsible for the carcinogenicity.

see more @  Hagland HR, Søreide K. Cellular metabolism in colorectal carcinogenesis:
Influence of lifestyle, gut microbiome and metabolic pathways. Cancer Lett. 2014 
Mar 12. pii: S0304-3835(14)00133-5. doi: 10.1016/j.canlet.2014.02.026.



Friday, 7 February 2014

Defining CIMP in epigenetics - a walk in the park?

Defining CIMP for correct classification of epigenetically altered tumors can be a challenging task, yet correct classification is very important for understanding tumor biology, identifying molecular classes that can explain differences in outcome or response to therapy, and for comparison between results from different groups.

We have recently added to the debate by comparing a set of commonly agreed panels to assess CIMP. The discrepancy between some of the markers and panels - and, depending on the number of genes and the number of probes in each gene included - was considerable and (maybe) even disturbing!

read the full text paper published in Plos One, if you would like to read beyond the abstract:

PLoS One. 2014 Jan 21;9(1):e86657. doi: 10.1371/journal.pone.0086657. eCollection 2014.

Comparison of CpG Island Methylator Phenotype (CIMP) Frequency in Colon Cancer Using Different Probe- and Gene-Specific Scoring Alternatives on Recommended Multi-Gene Panels.

Berg M1, Hagland HR2, Søreide K3.


Abstract

BACKGROUND:

In colorectal cancer a distinct subgroup of tumours demonstrate the CpG island methylator phenotype (CIMP). However, a consensus of how to score CIMP is not reached, and variation in definition may influence the reported CIMP prevalence in tumours. Thus, we sought to compare currently suggested definitions and cut-offs for methylation markers and how they influence CIMP classification in colon cancer.

METHODS:

Methylation-specific multiplex ligation-dependent probe amplification (MS-MLPA), with subsequent fragment analysis, was used to investigate methylation of tumour samples. In total, 31 CpG sites, located in 8 different genes (RUNX3, MLH1, NEUROG1, CDKN2A, IGF2, CRABP1, SOCS1 and CACNA1G) were investigated in 64 distinct colon cancers and 2 colon cancer cell lines. The Ogino gene panel includes all 8 genes, in addition to the Weisenberger panel of which only 5 of the 8 genes included were investigated. In total, 18 alternative combinations of scoring of CIMP positivity on probe-, gene-, and panel-level were analysed and compared.

RESULTS:

For 47 samples (71%), the CIMP status was constant and independent of criteria used for scoring; 34 samples were constantly scored as CIMP negative, and 13 (20%) consistently scored as CIMP positive. Only four of 31 probes (13%) investigated showed no difference in the numbers of positive samples using the different cut-offs. Within the panels a trend was observed that increasing the gene-level stringency resulted in a larger difference in CIMP positive samples than increasing the probe-level stringency. A significant difference between positive samples using 'the most stringent' as compared to 'the least stringent' criteria (20% vs 46%, respectively; p<0.005) was demonstrated.

CONCLUSIONS:

A statistical significant variation in the frequency of CIMP depending on the cut-offs and genes included in a panel was found, with twice as many positives samples by least compared to most stringent definition used.




Saturday, 21 December 2013

Freebies from the BJS: Emergency surgery issue launched hot from the press!!!

Now it is available for access and free download: The themed Emergency surgery issue is now published on the BJS website and can be searched up in Pubmed.

Go to this link to access the content!

Have a Merry Xmas everyone!!!



Volume 101 Issue 1 (January 2014)

Leading articles

Improving outcomes in emergency surgery 

  • Author:A. Bergenfelz, K. Søreide
  • Published: Nov 27, 2013
  • Pages: e1-e2

Barriers, regulations and solutions in emergency surgery research 

  • Author:T. J. Coats
  • Published: Nov 25, 2013
  • Pages: e3-e4

Checklists and crisis management in surgical emergencies 

  • Author:K. Ram, M. A. Boermeester
  • Published: Nov 13, 2013
  • Pages: e5-e6

Organization of emergency surgery 

  • Author:A. Leppäniemi
  • Published: Nov 13, 2013
  • Pages: e7-e8

Reviews

Global disease burden of conditions requiring emergency surgery 

  • Author:B. Stewart, P. Khanduri, C. McCord, M. Ohene‐Yeboah, S. Uranues, F. Vega Rivera, C. Mock
  • Published: Nov 25, 2013
  • Pages: e9-e22

Commentary

Global disease burden of conditions requiring emergency surgery ( Br J Surg 2014; 101: e9–e22) 

  • Author:R. T. Petroze
  • Published: Dec 12, 2013
  • Pages: e23-e23

Reviews

Contemporary management of abdominal surgical emergencies in infants and children 

  • Author:L. W. E. van Heurn, M. P. Pakarinen, T. Wester
  • Published: Nov 29, 2013
  • Pages: e24-e33

Multidisciplinary management strategies for acute non‐variceal upper gastrointestinal bleeding 

  • Author:Y. Lu, R. Loffroy, J. Y. W. Lau, A. Barkun
  • Published: Nov 26, 2013
  • Pages: e34-e50

Strategies to improve the outcome of emergency surgery for perforated peptic ulcer 

  • Author:K. Søreide, K. Thorsen, J. A. Søreide
  • Published: Nov 29, 2013
  • Pages: e51-e64

Staged multidisciplinary step‐up management for necrotizing pancreatitis 

Saturday, 30 November 2013

Abdominal emergencies in children - free paper

Please access this link to read the full text paper on "Contemporary management of acute abdominal emergencies in infants and children" just published in the BJS and free to access online.

The paper deals with update info on acute appendicitis, hernia, intestinal malrotation and/or strangulation, pyloric stenosis, intussusception and a handful of other conditions that may present to the general surgeon on call.

Illustration of malrotation, from the paper by van Heurn and colleagues in the BJS. Source: 
British Journal of Surgery 29 NOV 2013 DOI: 10.1002/bjs.9335
http://onlinelibrary.wiley.com/doi/10.1002/bjs.9335/full#bjs9335-fig-0001

Coming up: Emergency surgery issue in the BJS

A collective sieries on emergency surgery conditions will be launched in the January issue of the BJS. All papers will be free to access, either via PubMed searches or direct through the BJS website (or, most conveniently probably by downloading the BJS app for iPad, makes it easier to read on your tablet).

A leader to introduce the series has recently been launched and can be accessed here.

I will try to introduce some of the papers as they are real eased early online - I believe there are plenty material that will be of great use and interest to a worldwide readership.

Excited to have your response as we go!

Cheers,

Kjetil


Friday, 8 November 2013

Centenary Talks given at ASGBI, Glasgow and ACS, Washington 2013

Related to the BJS centenary a symposium was held at the International Surgical Congress of the Associations of Surgeons of Great Britain & Ireland in Glasgow, May 2013. You can find all the lectures to the ASGBI 2013 BJS Symposium: 100 years of BJS by going to the BJS website.
Also, a co-anniversary was held in Washington DC, marking the 100 years of both the BJS and the American College of Surgeons. The symposium can be view in entirety here.

Saturday, 26 October 2013

International collaboration in surgical research: Lancet paper

The Lancet
I very recently had the privilege to be leading a group of authors under the acronym IRIS working group (Int'l Research collaboration In Surgery) to produce a report on the current state of research collaboration across borders in surgery and suggestions as to how this can be improved for the future.
Considering the huge number of surgeries performed worldwide each year - it is estimated at 245 million operations, and not taking into account that a large part of surgeons' work consists also of non-operative management of surgical disease - the number of patients that are accrued or contributing to trials is a mere minimum, likely far below 1% of all surgeries performed.

In the paper it is being discussed the different types of strategies that can be explored to increase collaboration and involvement in research for surgeons. Obviously this is but a starting point and there is a lot more to be said and even more to be done to rectify the current state of surgical trial activity.

You can read the full paper at the Lancet or search the reference at the bottom page here.

Please do get in contact should you have any ideas or would like to get involved from your part in this.
You can send me any note (or request for the full paper) through this link.

The Lancet, Volume 382, Issue 9898, Pages 1140 - 1151, 28 September 2013, doi:10.1016/S0140-6736(13)61455-5.

Friday, 27 September 2013

Lymph nodes in colon cancer

For patients undergoing curative resections for colon cancer, the nodal status (presence or not of metastatic cells in the lymph nodes) represents the strongest prognostic factor, yet at the same time it is one of the most disputed issues as well in colorectal cancer staging. We have investigated this topic over the past several years (see references 1-6 listed below).

You can read the fulltext article on qualitative and quantitative aspects of lymph nodes in colon cancer here.
reproduced from Veen et al. Dig Surg, 2013


As a consequence of this ongoing dispute, the qualitative and quantitative aspects of lymph node evaluation are being scrutinized beyond the blunt distinction between 'node positive' (pN+) and 'node negative' (pN0) disease. 

Controversy ranges from a minimal or 'least-unit' strategy as exemplified by the 'sentinel node' (see f.ex. reference 3 below) to a maximally invasive or 'all inclusive' approach by extensive surgery. 
Ranging between these two extremes of node sampling strategies are factors of quantitative and qualitative value, which may be subject to modification. 

reproduced from Veen et al. Dig Surg, 2013.

Qualitative issues may include aspects of lymph node harvest reflected by surgeon, pathologist and even hospital performance, which all may be subject to modification. However, patient's age, gender and genotype may be non-modifiable, yet influence node sample. 

Quantitative issues may reflect the balance between absolute numbers and models investigating the relationships of positive to negative nodes (lymph node ratio; log odds of positive lymph nodes).

Read the full text article (link is available above) and let me know your opinion on this!

1: Berg M, Guriby M, Nordgård O, Nedrebø BS, Ahlquist TC, Smaaland R, Oltedal S, 
Søreide JA, Kørner H, Lothe RA, Søreide K. Influence of microsatellite
instability, KRAS and BRAF mutations on lymph node harvest in stage I-III colon
cancers. Mol Med. 2013 Aug 21. doi: 10.2119/molmed.2013.00049. [Epub ahead of
print] PubMed PMID: 23979710. 

2: Veen T, Nedrebø BS, Stormark K, Søreide JA, Kørner H, Søreide K. Qualitative
and Quantitative Issues of Lymph Nodes as Prognostic Factor in Colon Cancer. Dig 
Surg. 2013 Apr 10;30(1):1-11.  


3: Nordgård O, Oltedal S, Aasprong OG, Søreide JA, Søreide K, Tjensvoll K, Gilje 
B, Heikkilä R, Guriby M, Lothe RA, Smaaland R, Kørner H. Prognostic relevance of 
occult metastases detected by cytokeratin 20 and mucin 2 mRNA levels in sentinel 
lymph nodes from colon cancer patients. Ann Surg Oncol. 2012 Nov;19(12):3719-26. 
doi: 10.1245/s10434-012-2454-8. Epub 2012 Jul 3. PubMed PMID: 22752373. 


4: Søreide K. Lymph node evaluation for colon cancer. JAMA. 2011 Dec
28;306(24):2669; author reply 2669. doi: 10.1001/jama.2011.1882. PubMed PMID:
22203534. 


5: Nedrebø BS, Søreide K, Nesbakken A, Eriksen MT, Søreide JA, Kørner H;
Norwegian Colorectal Cancer Group. Risk factors associated with poor lymph node
harvest after colon cancer surgery in a national cohort. Colorectal Dis. 2013
Jun;15(6):e301-8. doi: 10.1111/codi.12245. PubMed PMID: 23582027. 


6: Søreide K, Nedrebø BS, Søreide JA, Slewa A, Kørner H. Lymph node harvest in
colon cancer: influence of microsatellite instability and proximal tumor
location. World J Surg. 2009 Dec;33(12):2695-703. doi: 10.1007/s00268-009-0255-4.
PubMed PMID: 19823901.

Tuesday, 25 June 2013

BJS news: new website, new app and the newest impact factor!

IF is out today and BJS is climbing! Although not yet back at the all-time-high in 2008 (at 4.921) it is currently at 4.839.

We are now second overall! (Only after Annals - which continues to decrease considerably, from 7.49 to 6.33 = biggest drop in the category!).

Excluding the others in the "surgery" category (some of which are really not competitors, such as Am J Surg Pathol, Endoscopy and Am J Transplant):

Third place is held by JACS (steady from last year at 4.5),
Surg Obest Rel Dis has increased to 4.12
Ann Surg Oncol, steady at 4.12
Archives declined from 4.4 to 4.1
Surgery declined to 3.3….etc etc

This just to give a few details form the surgical field of the IF.

Good thing is that we are among the very few top surgical journals with an increase (and in IF, when several others see no progress or even continued decline! For what it' worth (yes, IF is not everything) I think it is a sign of the efforts put into the Journal (I hope).

Next year we'll break the 5.0 barrier!


And... the newly refreshed web-page of the BJS is out, please click here for a view!

Finally, and a much awaited tool for BJS readers, is the new BJS app for iPad, which is downloadable at the BJS homepage, or through this link here.



Sunday, 16 June 2013

Frontiers | Using Patient-Reported Outcome Measures for Improved Decision-Making in Patients with Gastrointestinal Cancer – the Last Clinical Frontier in Surgical Oncology? | Frontiers in Surgical Oncology

Frontiers | Using Patient-Reported Outcome Measures for Improved Decision-Making in Patients with Gastrointestinal Cancer – the Last Clinical Frontier in Surgical Oncology? | Frontiers in Surgical Oncology

Patient-reported outcome measures (PROMs)

Patient reported data (PROMs) is the "new wine" in clinical research. It is not really new, but increased focus on the patient-reported outcomes has gained increased interest from both the point of decision-makers as well as the public itself. Doctors used to make decisions based on the risk-benefit ratio of morbidity/mortality to the gains in health intervention (and off course, still do) but now comes the added value of information obtained from the patient itself. Indeed, it might be so that patients evaluate and appreciate certain risks and benefits different than the doctor, and then this should be incorporated into the decision making process.
From Søreide & Søreide, Frontiers Oncology 2013.
We have currently published to papers dealing with PROMs. One is a perspectives article published in Frontiers in Surgical Oncology (To view the online publication, please click here: article).

Using patient-reported outcome measures for improved decision-making in patients with gastrointestinal cancer – the last clinical frontier in surgical oncology?
Kjetil Søreide1,2* and Annbjørg H. Søreide3


Front. Oncol. 3:157. doi: 10.3389/fonc.2013.00157


The other one is an article investigating PROMs in patients undergoing ERCP. In short, although a high number of patients experienced pain during the procedure, the vast majority were satisfied with the procedure and treatment. However, the findings gives reason to investigate how sedation procedures can be optimized during ERCP. The abstract can be found at (abstract).


Patient-reported outcome measures after endoscopic retrograde cholangiopancreatography: a prospective, multicentre study.Glomsaker TB, Hoff G, Kvaløy JT, Søreide K, Aabakken L, Søreide JA; On behalf of the Norwegian Gastronet ERCP group.
 2013 May 31. [Epub ahead of print]

Saturday, 8 June 2013

Trauma epidemiology in Norway

Another PhD is done and dusted... 
It was a pleasure to attend this week's dissertation in Oslo when Thomas Kristiansen defended his thesis "Epidemiology and management of traumatic injuries: a population-based study of fatal trauma and assessment of geographical challenges in the organisation of trauma care " at the Diaconess Hospital. Great job and work well done! I've had the pleasure of being co-supervisor and co-author on several of his works. The first paper we co-wrote was on trauma systems in the Nordic countries (Trauma systems and early management of severe injuries in Scandinavia: review of the current state.) 
From T Kristiansen et al  2010 May;41(5):444-52. doi: 10.1016/j.injury.2009.05.027. Epub 2009 Jun 21.
Thomas has later published a series of paper (one yet to be published, but is now in final revisions) that constitutes the material for his thesis and PhD:


1: Kristiansen T, Rehn M, Gravseth HM, Lossius HM, Kristensen P. Paediatric trauma mortality in Norway: a population-based study of injury characteristics and urban-rural differences
trauma mortality in Norway: a population-based study of injury characteristicsand urban-rural differences. Injury. 2012 Nov;43(11):1865-72. doi:
10.1016/j.injury.2011.08.011. Epub 2011 Sep 21. PubMed PMID: 21939971.
2: Kristiansen T, Ringdal KG, Skotheimsvik T, Salthammer HK, Gaarder C, Naess PA,
Lossius HM. Implementation of recommended trauma system criteria in south-eastern Norway: a cross-sectional hospital surveyNorway: a cross-sectional hospital survey. Scand J Trauma Resusc Emerg Med. 2012
Jan 26;20:5. doi: 10.1186/1757-7241-20-5. PubMed PMID: 22281020; PubMed Central
PMCID: PMC3285082.
3: Kristiansen T, Lossius HM, Søreide K, Steen PA, Gaarder C, Næss PA. Patients Referred to a Norwegian Trauma Centre: effect of transfer distance on injury patterns, use of resources and outcomesReferred to a Norwegian Trauma Centre: effect of transfer distance on injurypatterns, use of resources and outcomes. J Trauma Manag Outcomes. 2011 Jun
16;5(1):9. doi: 10.1186/1752-2897-5-9. PubMed PMID: 21679393; PubMed Central
PMCID: PMC3135518.
4: Thomas Kristiansen, Hans M Lossius, Marius Rehn, Petter
Kristensen, Hans M Gravseth, Jo Røislien and Kjetil Søreide. Epidemiology of Trauma: a population-based study of geographical risk factors for injury deaths in the working-age population of Norway. (in press soon)


Thomas K. (far left) together with the members of the evaluation committee - and after having received the final verdict! Sigh of relief!


In addition to the work above I have previously investigated aspects of trauma epidemiology from other perspectives. One of the earliest experiences was to investigate the epidemiology of trauma deaths in our region (Stavanger area) which was published in World J Surg, 2007. In this paper, and in subsequent correspondence (Injury 2008; World J Surg 2010) and editorial work (BJS 2009), we discussed the principle of the "trimodal temporal death distribution", which I believe is a great educational model for explaining the temporal differences in relation to death causes (i.e immediate death usually occurs from non-salvagable bleeding or brain damage, most frequently outside hospital and following the accident/incident; early deaths occur from rapid bleeding that is not stopped or brain injuries not intervened on; later deaths may occur from insults to the brain, and the final mode of death is from the organ failures that follows the initial injuries). While serving a purpose as educational tool, it is simplified and obviously there is great overlap in modes and time-phrames that the researcher needs to see in relation. Also, the distribution will change somewhat from region to region, depending on the dominating mechanisms of trauma etc. If you'd like to know more details oabout this, please seek up any of the refs below or fell free to send me an email for a reprint (ksoreide@mac.com):


1: Søreide K. Temporal patterns of death after trauma: evaluation of circadian,
diurnal, periodical and seasonal trends in 260 fatal injuries. Scand J Surg.
2010;99(4):235-9. PubMed PMID: 21159595.

2: Søreide K. Epidemiology of trauma deaths: location, location, location! World 
J Surg. 2010 Jul;34(7):1720-1; author reply 1722-3. doi:
10.1007/s00268-010-0434-3. PubMed PMID: 20112018.

3: Meling T, Harboe K, Søreide K. Incidence of traumatic long-bone fractures
requiring in-hospital management: a prospective age- and gender-specific analysis
of 4890 fractures. Injury. 2009 Nov;40(11):1212-9. doi:
10.1016/j.injury.2009.06.003. Epub 2009 Jul 5. PubMed PMID: 19580968.

4: Søreide K. Epidemiology of major trauma. Br J Surg. 2009 Jul;96(7):697-8. doi:
10.1002/bjs.6643. PubMed PMID: 19526611.

5: Søreide K, Krüger AJ, Ellingsen CL, Tjosevik KE. Pediatric trauma deaths are
predominated by severe head injuries during spring and summer. Scand J Trauma
Resusc Emerg Med. 2009 Jan 22;17:3. doi: 10.1186/1757-7241-17-3. PubMed PMID:
19161621; PubMed Central PMCID: PMC2637226.

6: Krüger AJ, Søreide K. Trimodal temporal distribution of fatal trauma--fact or 
fiction? Injury. 2008 Aug;39(8):960-1; author reply 961-2. doi:
10.1016/j.injury.2008.01.007. Epub 2008 Jun 30. PubMed PMID: 18586249.

7: Søreide K, Krüger AJ, Vårdal AL, Ellingsen CL, Søreide E, Lossius HM.
Epidemiology and contemporary patterns of trauma deaths: changing place, similar 
pace, older face. World J Surg. 2007 Nov;31(11):2092-103. PubMed PMID: 17899256.


Monday, 6 May 2013

Success in the Stavanger Surgical Research Group

My absence from the blog recently is due to an extensive work load over the past few months, yet with a pleasure twist, as three of the candidates in our research group have defended their PhD thesis over the past several weeks. Here are the summaries and brief overview of the champs!
Terje Meling MD defended his thesis on "Implementation of a fracture and dislocation registry. Epidemiology and scoring validity of long-bone fractures" based on the publications:


Meling T, Harboe K, Enoksen CH, Aarflot M, Arthursson AJ, Søreide K.
Acta Orthop. 2013 Apr;84(2):207-12. doi: 10.3109/17453674.2012.752692. Epub 2012 Dec 18.
Meling T, Harboe K, Enoksen CH, Aarflot M, Arthursson AJ, Søreide K.
J Trauma Acute Care Surg. 2012 Jul;73(1):224-31. doi: 10.1097/TA.0b013e31824cf0ab.
Meling T, Harboe K, Arthursson AJ, Søreide K.
Scand J Trauma Resusc Emerg Med. 2010 Oct 18;18:54. doi: 10.1186/1757-7241-18-54.
Meling T, Harboe K, Søreide K.
Injury. 2009 Nov;40(11):1212-9. doi: 10.1016/j.injury.2009.06.003.

Tom Glomsaker MD defended his work on the use of ERCP in Norway, with the thesis entitled "ERCP in Norway. Patterns of activity and undesired events " and based on the publications as follows:

Glomsaker T, Hoff G, Kvaløy JT, Søreide K, Aabakken L, Søreide JA; Norwegian Gastronet ERCP Group.
Br J Surg. 2013 Feb;100(3):373-80. doi: 10.1002/bjs.8992. Epub 2012 Dec 6.
Glomsaker T, Søreide K, Hoff G, Aabakken L, Søreide JA; Norwegian Gastronet ERCP group.
Scand J Gastroenterol. 2011 Sep;46(9):1144-51. doi: 10.3109/00365521.2011.594085. 
Glomsaker T, Søreide K, Aabakken L, Søreide JA.
Scand J Gastroenterol. 2011 Jan;46(1):116-21. doi: 10.3109/00365521.2010.513063. Epub 2010 Aug 24. Erratum in: Scand J Gastroenterol. 2011 Jan;46(1):121.

And , last but not least, Bjørn Steinar Nedrebø MD, defended his thesis on "Colorectal Cancer in Norway - National Treatment Guidelines and Outcomes " of which his work is based on the publications :
Bjørn Steinar Nedrebø
Nedrebø B, Søreide K, Nesbakken A, Eriksen M, Søreide J, Kørner H; The Norwegian Colorectal Cancer Group.
Colorectal Dis. 2013 Apr 13. doi: 10.1111/codi.12245. [Epub ahead of print]

Nedrebø BS, Søreide K, Eriksen MT, Kvaløy JT, Søreide JA, Kørner H.
Acta Oncol. 2012 Oct 29. [Epub ahead of print]


Nedrebø BS, Søreide K, Eriksen MT, Dørum LM, Kvaløy JT, Søreide JA, Kørner H; Norwegian Colorectal Cancer Registry.
Br J Surg. 2011 May;98(5):716-23. doi: 10.1002/bjs.7426. Epub 2011 Feb 21.

Congrats and well done!!!